Tuesday, August 15, 2017

Indivumed Partnership Expands MHRI's Reach of Research

Collaboration takes many forms. Team members collaborate within a department and departments work together across MedStar.  These collaborations help us forward our vision to advance health for our patients today and tomorrow.

I was pleased to announce last week that MHRI formed a new collaboration with Indivumed, a Germany-based oncology company that helps us conduct research that individualize anti-cancer medical therapies through state-of-the-art bio-specimen collection, preservation and analysis.

This new agreement brings this state-of-the-art bio-specimen partnership to all MedStar hospitals so it can be applied for all cancer patients and their tumors.  We had some very productive kick-off organizational meetings with oncology, surgery and pathology leaders from across the system.

The full press release can be read here. Louis M. Weiner, MD, director of Georgetown Lombardi and Director of MedStar’s integrated cancer network, also posted about this great partnership on his blog.

No comments:

Post a Comment